Results from the MATTERHORN Phase III trial showed perioperative treatment with AstraZeneca’s (AZN) Imfinzi in combination with standard-of-care FLOT chemotherapy demonstrated a statistically ...

Positive high-level results from the MATTERHORN Phase III trial showed perioperative treatment with AstraZeneca’s (AZN) Imfinzi in combination with standard-of-care FLOT chemotherapy ...

AstraZeneca is preparing to talk to the FDA about a potential new use of its immunotherapy Imfinzi after a pivotal study in early-stage stomach cancer met its main goal. When added to a ...

To celebrate the 50th anniversary of the establishment of diplomatic relations between the Philippines and China, the ...

The Manila International Airport Authority (MIAA) unveiled its new logo during its 43rd Anniversary celebration on Friday.

AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company's story, from its creation as a merger of two equals, to its recent major ...

On Friday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the MATTERHORN Phase 3 trial evaluating Imfinzi (durvalumab) as a perioperative treatment for patients with resectable ...

AstraZeneca has unveiled plans to invest around $570 million in Canada and add around 700 new jobs, describing the county as a "growing global hub" for clinical trials. The C$820 million ...

Likewise, the increasing need for point-of-care testing (POCT) is propelling market growth, as biosensors offer fast and convenient diagnostic solutions beyond conventional healthcare facilities. LAS ...

Amidst the 43rd anniversary of the Manila International Airport Authority (MIAA), the agency unveiled its new logo. Much like ...

IN celebration of its 43rd anniversary, the Manila International Airport Authority (MIAA) on Friday night revealed its new logo. The airport authority's new logo consists of a Philippine eagle with ...